Prospective, multi-national, multicenter, single arm registry
Clinical Studies
Now enrolling
The Transform Trial for Overactive Bladder with Leakage
If you’re living with Overactive Bladder (OAB) and haven’t had lasting success with medications, you may qualify for the Transform Trial. The study is for the Silensa™ System – an investigational device designed to reduce urinary leakage and improve bladder function.
Tell me moreAmphora Medical is conducting clinical studies that help advance the medical care for patients with overactive bladder. Detailed information regarding all Amphora Medical clinical studies can be found at www.clinicaltrials.gov.
Current Clinical Studies are Closed to Patient Recruitment.
CARET 1 Clinical Study (NCT02398578)
-
Design
-
Study Phase
Phase 1 and 2
-
Study Goals
To demonstrate the safety of the Amphora OAB Device and assess change in OAB symptoms over time after treatment
-
Patient Population
Female OAB patients with and without incontinence
-
Countries Participating
Belgium and Canada
Additional information and a list of participating clinical sites can be found at www.clinicaltrials.gov
CARET 2 Clinical Study (NCT02480829)
-
Design
Two Phase Multicenter Feasibility Study
-
Study Phase
Phase 1 and 2
-
Study Goals
To evaluate safety and efficacy of the Amphora OAB System for treatment of urgency and frequency with or without urge incontinence caused by OAB.
-
Patient Population
Female OAB patients with and without incontinence
-
Countries Participating
United States
Additional information and a list of participating clinical sites can be found at www.clinicaltrials.gov